It has been reported that CASP8-652 6N ins/del polymorphism may affect the susceptibility to prostate cancer and reduce the risk of prostate cancer in Chinese men [21], while in other cancers it may be associated with cell death and tumor growth. Here, CASP8 is linked to prostate carcinoma.